SIRT1 and chronic obstructive pulmonary disease: Our results indicate that SIRT1 activators and possibly selective ATM inhibitors could be used therapeutically to inhibit the increased senescence in circulating endothelial progenitors in COPD patients with possible beneficial effects on endothelial function and CVD.